A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

Denmark

Aarhus University Hospital, Aarhus

United Kingdom

University Hospitals Sussex NHS Foundation Trust, Brighton

Western General Hospital, Edinburgh

Imperial College NHS Healthcare Trust, London

Barts Health NHS Trust, London

Chelsea And Westminster Hospital NHS Foundation Trust, London

Guy's and St Thomas' NHS Foundation Trust, London

Mortimer Market CNWL Hospital NHS Foundation Trust, London

Royal Free London NHS Foundation Trust, London

St Georges Hospital NHS Foundation Trust, London

Manchester University NHS Foundation Trust, Manchester

Oxford University Hospitals, Oxford